Q3 2022 Eurofins Scientific SE Trading Statement Call Transcript
Ladies and gentlemen, welcome, and thank you for joining Eurofins Q3 2022 Management Update. Please note that this call is being recorded and will later be available for replay on the Eurofins Investor Relations website. (Operator Instructions)
During this call, Eurofins' management may make forward-looking statements, including, but not limited to, statements with respect to outlook and the related assumptions. Management will also discuss alternative performance measures such as organic growth and EBITDA, which are defined in the footnotes of our press releases (inaudible) after materially from objectives discussed. Risks and uncertainties that may affect Eurofins' future results include, but are not limited to, those described in the Risk Factors section of the Eurofins' annual and half year report. Please also read the disclaimer on Page 2 of this presentation, subject to which this call and Q&A session are made.
I would now like to turn the conference over to Dr. Gilles Martin, Eurofins' CEO. Please go ahead.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |